These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 34704283)

  • 1. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
    Cirbus K; Simone P; Austin Szwak J
    J Clin Pharm Ther; 2022 Jan; 47(1):112-118. PubMed ID: 34704283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
    Davis KA; Davis DO
    Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia.
    Albuloushi A; Rhoten M; Kelly J; Sylvester KW; Grandoni J; Connors JM
    J Thromb Thrombolysis; 2022 Nov; 54(4):597-604. PubMed ID: 36129561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban as an Alternative Agent for Heparin-Induced Thrombocytopenia.
    Farasatinasab M; Zarei B; Moghtadaei M; Nasiripour S; Ansarinejad N; Zarei M
    J Clin Pharmacol; 2020 Oct; 60(10):1362-1366. PubMed ID: 32519800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.
    Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Wu C; Nazi I; Crowther MA
    J Thromb Haemost; 2016 Jun; 14(6):1206-10. PubMed ID: 27061271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.
    Joseph L; Casanegra AI; Dhariwal M; Smith MA; Raju MG; Militello MA; Gomes MP; Gornik HL; Bartholomew JR
    J Thromb Haemost; 2014 Jul; 12(7):1044-53. PubMed ID: 24766902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.
    Warkentin TE; Pai M; Linkins LA
    Blood; 2017 Aug; 130(9):1104-1113. PubMed ID: 28646118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review.
    Sadowski C; Reinert JP
    Am J Health Syst Pharm; 2024 Sep; 81(19):e584-e593. PubMed ID: 38651828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Open-Label, Single-Arm, Pilot Intervention Study to Assess the Efficacy and Safety of Apixaban in Heparin-Induced Thrombocytopenia.
    Farasatinasab M; Balouchzehi S; Moghaddam OM; Ansarinejad N; Mohammadi M; Nasiripour S
    J Clin Pharmacol; 2022 Nov; 62(11):1379-1384. PubMed ID: 35656855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Direct Oral Anticoagulants on Anti-Factor Xa Measurements Utilized for Monitoring Heparin.
    Macedo KA; Tatarian P; Eugenio KR
    Ann Pharmacother; 2018 Feb; 52(2):154-159. PubMed ID: 28862013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].
    Rivera O G; Corsi S O; Pavlovic J A; Aizman S A; Varas A P
    Rev Med Chil; 2017 Sep; 145(9):1213-1217. PubMed ID: 29424412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Role of Direct Oral Anticoagulants in the Management of Heparin-induced Thrombocytopenia.
    Barlow A; Barlow B; Reinaker T; Harris J
    Pharmacotherapy; 2019 Aug; 39(8):837-853. PubMed ID: 31233222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Infarction with Limb Arterial and Venous Thrombosis in a Patient with Enoxaparin-Induced Thrombocytopenia.
    Singh N; Singh Lubana S; Tsai HM
    Am J Case Rep; 2020 May; 21():e922498. PubMed ID: 32469847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant.
    Arachchillage DR; Besser M; Maclean R; Baglin T; van Veen JJ
    Thromb Res; 2016 Jul; 143():137-40. PubMed ID: 27244105
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis.
    Murray PT; Hursting MJ
    Ren Fail; 2006; 28(7):537-9. PubMed ID: 17050234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.
    Hvas AM; Favaloro EJ; Hellfritzsch M
    Expert Rev Hematol; 2021 Apr; 14(4):335-346. PubMed ID: 33736552
    [No Abstract]   [Full Text] [Related]  

  • 17. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
    Wang Y; Zhang K; Yin L; Fu G; Liu Z
    Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e7. PubMed ID: 34656708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the rivaroxaban for heparin-induced thrombocytopenia study.
    Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Crowther MA
    J Thromb Thrombolysis; 2014 Nov; 38(4):485-92. PubMed ID: 24549975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
    J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location.
    Janczak DT; Mimier MK; McBane RD; Kamath PS; Simmons BS; Bott-Kitslaar DM; Lenz CJ; Vargas ER; Hodge DO; Wysokinski WE
    Mayo Clin Proc; 2018 Jan; 93(1):40-47. PubMed ID: 29217335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.